Jonathan Nebeker, MD, MS

Languages spoken: English, French

Academic Information

Departments: Internal Medicine - Professor

Divisions: Geriatrics

Academic Office Information

Jonathan.Nebeker@hsc.utah.edu

Board Certification

  • American Board of Preventive Medicine (Clinical Informatics)

Research Interests

  • Operations Research
  • Machine Learning Artificial Intelligence
  • Adverse Drug Reaction Reporting Systems
  • Computerized Medical Decision Making
  • Health Services Research
  • Drug Therapy, Computer-Assisted
  • Pharmacoepidemiology

Dr. Nebeker is Chief Medical Informatics Officer (CMIO) at Veterans Health Administration (VHA) central office and Professor of Medicine at the University of Utah. His degrees and training took place at Harvard and the University of Pennsylvania. He practices geriatrics at the Salt Lake City VA Medical Center.

He has been the clinical and/or informatics lead of all EHR-related programs at VA from 2014 through present. He works with other federal agencies and industry associations on standards and best practices to help VHA participate in markets of health IT and content. He recently catalyzed VA's modernization of its analytical platform and is leading with IT partners the VA digital health strategy.

His research has three areas of focus: adverse drug events, human interface design, and analytical systems/advanced process analysis. His work concerning the characterization, epidemiology, and prevention of adverse drug events is widely cited. Much of this work concerns how EHRs help or don’t help prevent these events. From 2005 through 2015, he focused on translating basic science of cognitive and social psychology to medical informatics and EHR design. Randomized controlled trials of his novel user-interface designs have demonstrated increased accuracy of and decreased time to diagnosis of medical conditions. He incorporates these lessons into the design of VA’s EHR systems. In 2008, he established the scientific computing infrastructure for Veterans Health Administration. His research now focuses on machine learning and artificial intelligence for human and electronic process control in support of a highly reliable, learning health system.

Research Statement

Dr. Nebeker directs active research projects on translating theory from the cognitive and social sciences to guide the design of software for clinicians, for real-time surveillance of safe operation and safe use of EHR systems, and for design of information systems for real-time analytics.

Education History

Fellowship University of Utah School of Medicine
Geriatrics 		Fellow
Residency Beth Israel Deaconess Medical Center
Internal Medicine 		Resident
Internship New England Deaconess Hospital
Internal Medicine 		Intern
Graduate Training University of Pennsylvania
Education 		M.S.
Professional Medical University of Pennsylvania
Medicine 		M.D.
Undergraduate Harvard University
History and Science 		A.B.

Selected Publications

  1. Pfaff MS, Eris O, Weir C, Anganes A, Crotty T, Rahman M, Ward M, Nebeker JR (2020). Analysis of the cognitive demands of electronic health record use. J Biomed Inform, 113, 103633.
  2. Pfaff MS, Eris O, Weir C, Anganes A, Crotty T, Rahman M, Ward M, Nebeker JR (2020). Analysis of the cognitive demands of electronic health record use. J Biomed Inform, 113.
  3. Butler JM, Gibson B, Lewis L, Reiber G, Kramer H, Rupper R, Herout J, Long B, Massaro D, Nebeker J (2020). Patient-centered care and the electronic health record: exploring functionality and gaps. JAMIA Open, 3(3), 360-368.
  4. Ozmen O, Klasky HB, Omitaomu OA, Olama M, Kuruganti T, Ward M, Scott JM, Laurio A, Drews F, Nebeker JR (2020). Feature Engineering and Process Mining to Enable Hazard Detection in Health Information Technology. AMIA Jt Summits Transl Sci Proc, 2020, 469-476.
  5. Brown SH, Stevenson L, Territo DJ, Kilbourne J, Nebeker JR, Miller H, Lincoln MJ (2020). One-Way and Round-Trip Analysis Demonstrates Surprising Limitations of Standards-Based Terminology Maps. AMIA Annu Symp Proc, 2019, 258-266.
  6. DuVall SL, Matheny ME, Ibragimov IR, Oats TD, Tucker JN, South BR, Turano A, Saoudian H, Kangas C, Hofmann K, Funk W, Nichols C, Bonnema A, Ferrucci L, Nebeker JR (2019). A Tale of Two Databases: The DoD and VA Infrastructure for Clinical Intelligence (DaVINCI). Stud Health Technol Inform, 264, 1660-1661.
  7. Omitaomu OA, Ozmen O, Olama MM, Pullum LL, Kuruganti T, Nutaro J, Klasky HB, Zandi H, Advani A, Laurio AL, Ward M, Scott J, Nebeker JR (2019). Real-Time Automated Hazard Detection Framework for Health Information Technology Systems. Health Syst (Basingstoke), 8(3), 190-202.
  8. Olufemi A Omitaomu, Ozgur Ozmen, Mohammed M Olama, Laura L Pullum, Teja Kuruganti, James Nutaro, Hilda B Klasky, Helia Zandi, Aneel Advani, Angela L Laurio, Merry Ward, Jeanie Scott, Jonathan R Nebeker (05/07/2019). Real-Time Automated Hazard Detection Framework for Health Information Technology Systems, Health Systems. Health Syst (Basingstoke).
  9. Olufemi A Omitaomu, Ozgur Ozmen, Mohammed M Olama, Laura L Pullum, Teja Kuruganti, James Nutaro, Hilda B Klasky, Helia Zandi, Aneel Advani, Angela L Laurio, Merry Ward, Jeanie Scott, Jonathan R Nebeker (2019). Real-Time Automated Hazard Detection Framework for Health Information Technology Systems. Health Syst (Basingstoke), 1-13.
  10. Legler A, Price M, Parikh M, Nebeker JR, Ward MC, Wedemeyer L, Pizer SD (2019). Effect on VA Patient Satisfaction of Provider's Use of an Integrated Viewer of Multiple Electronic Health Records. J Gen Intern Med, 34(1), 132-136.
  11. Donahue M, Bouhaddou O, Hsing N, Turner T, Crandall G, Nelson J, Nebeker J (2018). Veterans Health Information Exchange: Successes and Challenges of Nationwide Interoperability. AMIA Annu Symp Proc, 2018, 385-394.
  12. DAmore J, Bouhaddou O, Mitchell S, Li C, Leftwich R, Turner T, Rahn M, Donahue M, Nebeker J (2018). Interoperability Progress and Remaining Data Quality Barriers of Certified Health Information Technologies. AMIA Annu Symp Proc, 2018, 358-367.
  13. Boockvar KS, Ho W, Pruskowski J, DiPalo KE, Wong JJ, Patel J, Nebeker JR, Kaushal R, Hung W (2017). Effect of health information exchange on recognition of medication discrepancies is interrupted when data charges are introduced: results of a cluster-randomized controlled trial. J Am Med Inform Assoc, 24(6), 1095-1101.
  14. Burningham Z, He T, Teng CC, Zhou X, Nebeker J, Sauer BC (2017). Evaluation of the Case-Crossover (CCO) Study Design for Adverse Drug Event Detection. Drug Saf, 40(9), 789-798.
  15. Leecaster MK, Weir CR, Drews FA, Hellewell JL, Bolton D, Jones MM, Nebeker JR (2017). Translation of Contextual Control Model to chronic disease management: A paradigm to guide design of cognitive support systems. J Biomed Inform, 71S, S60-S67.
  16. Weir CR, Rubin MA, Nebeker J, Samore M (2017). Modeling the mind: How do we design effective decision-support? J Biomed Inform, 71S, S1-S5.
  17. Bouhaddou O, Davis M, Donahue M, Mallia A, Griffin S, Teal J, Nebeker J (2016). Automated Detection of Privacy Sensitive Conditions in C-CDAs: Security Labeling Services at the Department of Veterans Affairs. AMIA Annu Symp Proc, 2016, 332-341.
  18. Gundlapalli AV, Redd D, Gibson BS, Carter M, Korhonen C, Nebeker J, Samore MH, Zeng-Treitler Q (2015). Maximizing clinical cohort size using free text queries. Comput Biol Med, 60, 1-7.
  19. LaFleur J, Steenhoek CL, Horne J, Meier J, Nebeker JR, Mambourg S, Swislocki A, Carmichael J (2015). Comparing fracture absolute risk assessment (FARA) tools: an osteoporosis clinical informatics tool to improve identification and care of men at high risk of first fracture. Ann Pharmacother, 49(5), 506-14.
  20. Mull HJ, Rosen AK, Shimada SL, Rivard PE, Nordberg B, Long B, Hoffman JM, Leecaster M, Savitz LA, Shanahan CW, Helwig A, Nebeker JR (2015). Assessing the potential adoption and usefulness of concurrent, action-oriented, electronic adverse drug event triggers designed for the outpatient setting. EGEMS (Wash DC), 3(1), 1116.
  21. Sauer B, Nebeker JR, Shen S, West S, Shinogle JA, Xu W, Rupper R, Lohr KN, Samore M (2014). Methodological framework to identify possible adverse drug reactions using population-based administrative data. F1000Res, 3(258).
  22. Ohno-Machado L, Agha Z, Bell DS, Dahm L, Day ME, Doctor JN, Gabriel D, Kahlon MK, Kim KK, Hogarth M, Matheny ME, Meeker D, Nebeker JR, pSCANNER team (2014). pSCANNER: patient-centered Scalable National Network for Effectiveness Research. J Am Med Inform Assoc, 21(4), 621-6.
  23. Sauer BC, Nebeker JR, Shen S, Rupper R, Samore M (2014). Identification of possible adverse drug reactions using population-based administrative data. In Faculty of Pharmaceutical Sciences, Ubon Ratchathani University, Thailand (Eds.), Patient Safety Annu Symp, Ubon, Thailand: ISBN 978-974-523-265-5 (Thailand), Proc. 2011, 60-66.
  24. Sauer B, Nebeker J, Shen S, Rupper R, West S, Shinogle JA, Xu W, Lohr KN, Samore M (2014). Methodological framework to identify possible adverse drug reactions using population-based administrative data. F1000Res, 3, 258.
  25. Divita G, Zeng QT, Gundlapalli AV, Duvall S, Nebeker J, Samore MH (2014). Sophia: A Expedient UMLS Concept Extraction Annotator. AMIA Annu Symp Proc, 2014, 467-76.
  26. Sauer, BC, He Tao, Nebeker JR (04/30/2013). SAS® Tools for Transparent and Reproducible Research: Medication History Estimator. SAS® Global Forum 2013 proceedings, San Francisco: SAS®, 1-10.
  27. Nelson RE, Nebeker JR, Hayden C, Reimer L, Kone K, LaFleur J (2013). Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis. AIDS Behav, 17(1), 160-7.
  28. Nebeker JR (2013). Integrating Information Objects and Annotations in the Notional DoD-VA iEHR User Experience: Results from a randomized controlled trial on efficiency and accuracy of problem assessment and intervention specification [Abstract]. AMIA proceedings.
  29. Weir C, Drews FA, Butler J, Barrus RJ, Jones ML, Nebeker JR (2013). Support for contextual control in primary care: a qualitative analysis. AMIA Annu Symp Proc, 2013, 1463-71.
  30. Redd D, Rindflesch T, Nebeker J, Zeng-Treitler Q (2013). Improve Retrieval Performance on Clinical Notes: A Comparison of Four Methods. The 46th Hawaii International International Conference onSystems Science (HICSS- 46 2013), 2389 - 2397.
  31. Nelson RE, Nebeker JR, Hayden C, Reimer L, Kone K, LaFleur J (2013). Comparing adherence to two different HIV antiretroviral regimens: an instrumental variable analysis. AIDS Behav, 17(1), 160-7.
  32. Mergenhagen KA, Blum SS, Kugler A, Livote EE, Nebeker JR, Ott MC, Signor D, Sung S, Yeh J, Boockvar KS (2012). Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events. Am J Geriatr Pharmacother, 10(4), 242-50.
  33. Mergenhagen KA, Blum SS, Kugler A, Livote EE, Nebeker JR, Ott MC, Signor D, Sung S, Yeh J, Boockvar K (2012). Pharmacist- versus physician-initiated admission medication reconciliation: impact on adverse drug events. Am J Geriatr Pharmacother, 10(4), 242-50.
  34. Nelson RE, Nebeker JR, Sauer BC, LaFleur J (2012). Factors associated with screening or treatment initiation among male United States veterans at risk for osteoporosis fracture. Bone, 50(4), 983-8.
  35. LaFleur J, Nelson RE, Yao Y, Adler RA, Nebeker JR (2012). Validated risk rule using computerized data to identify males at high risk for fracture. Osteoporos Int, 23(3), 1017-27.
  36. Zeng QT, Redd D, Rindflesch T, Nebeker J (2012). Synonym, topic model and predicate-based query expansion for retrieving clinical documents. AMIA Annu Symp Proc, 2012, 1050-9.
  37. Weir C, Drews FA, Leecaster MK, Barrus RJ, Hellewell JL, Nebeker JR (2012). The orderly and effective visit: impact of the electronic health record on modes of cognitive control. AMIA Annu Symp Proc, 2012, 979-87.
  38. Qing T Zeng, Doug Redd, Guy Divita, SamahJarad, Cynthia Brandt, Jonathan R Nebeker (12/26/2011). Characterizing Clinical Text and Sublanguage: A Case Study of the VA Clinical Notes. J Health Med Inform.
  39. Zeng QT, Redd D, Divita G, Jarad S, Brandt C, Nebeker JR (2011). Characterizing Clinical Text and Sublanguage: A Case Study of the VA Clinical Notes. J Health Med Inform, S3, 1-9.
  40. LaFleur J, Nelson RE, Sauer BC, Nebeker JR (2011). Overestimation of the effects of adherence on outcomes: a case study in healthy user bias and hypertension. Heart, 97(22), 1862-9.
  41. Boockvar KS, Santos SL, Kushniruk A, Johnson C, Nebeker JR (2011). Medication reconciliation: barriers and facilitators from the perspectives of resident physicians and pharmacists. J Hosp Med, 6(6), 329-37.
  42. Mull HJ, Nebeker JR, Shimada SL, Kaafarani HM, Rivard PE, Rosen AK (2011). Consensus building for development of outpatient adverse drug event triggers. J Patient Saf, 7(2), 66-71.
  43. Olola CH, Narus S, Nebeker J, Poynton M, Hales J, Rowan B, LeSieur H, Zumbrennen C, Edwards AA, Crawford R, Amundsen S, Kabir Y, Atkin J, Newberry C, Young J, Hanifi T, Risenmay B, Sorensen T, Evans RS (2011). The perception of medical professionals and medical students on the usefulness of an emergency medical card and a continuity of care report in enhancing continuity of care. Int J Med Inform, 80(6), 412-20.
  44. LaFleur J, Nelson RE, Yao Y, Adler RA, Nebeker JR (2011). Validated risk rule using computerized data to identify males at high risk for fracture. Osteoporos Int.
  45. Boockvar KS, Blum S, Kugler A, Livote E, Mergenhagen KA, Nebeker JR, Signor D, Sung S, Yeh J (2011). Effect of admission medication reconciliation on adverse drug events from admission medication changes. Arch Intern Med, 171(9), 860-1.
  46. Sauer BC, Shen S, Nebeker J, Rupper R, Samore M (2011). Identification of Possible Adverse Drug Reactions using Population-based Administrative Data. Patient Safety Annu Symp Proc, Detroit, 1(1), 60-66.
  47. LaFleur J, McAdam-Marx C, Alder SS, Sheng X, Asche CV, Nebeker J, Brixner DI, Silverman SL (2011). Clinical risk factors for fracture among postmenopausal patients at risk for fracture: a historical cohort study using electronic medical record data. J Bone Miner Metab, 29(2), 193-200.
  48. Rosen AK, Mull HJ, Kaafarani H, Nebeker J, Shimada S, Helwig A, Nordberg B, Long B, Savitz LA, Shanahan CW, Itani K (2011). Applying trigger tools to detect adverse events associated with outpatient surgery. J Patient Saf, 7(1), 45-59.
  49. Olola CH, Narus S, Poynton M, Nebeker J, Hales J, Rowan B, Smith M, Evans RS (2011). Patient-perceived usefulness of an emergency medical card and a continuity-of-care report in enhancing the quality of care. Int J Qual Health Care, 23(1), 60-7.
  50. DuVall SL, South BR, DAvolio LW, Shen S, Boone KW, Gundlapalli AV, Nebeker JR, Samore MH (2011). Creating Reusable Annotated Corpora Using the Clinical Document Architecture. Hawaii International Conference on System Sciences (HICSS), Koloa, HI: IEEE Society.
  51. Boockvar KS, Blum, SS, Kugler AJ, Livote E, Mergenhagen, KA, Nebeker J, Signor, D, Sung S, Yeh, J (2011). Effect of Admission Medication Reconciliation on Adverse Drug Events in Hospitalized Veterans. VA Healther Services Research and Development Annual Conference, Washington DC: Dept. of Veterans Affairs.
  52. Kushniruk AW, Santos SL, Pourakis G, Nebeker JR, Boockvar KS (2011). Cognitive analysis of a medication reconciliation tool: applying laboratory and naturalistic approaches to system evaluation. Stud Health Technol Inform, 164, 203-7.
  53. Kaafarani HM, Rosen AK, Nebeker JR, Shimada S, Mull HJ, Rivard PE, Savitz L, Helwig A, Shin MH, Itani KM (2010). Development of trigger tools for surveillance of adverse events in ambulatory surgery. Qual Saf Health Care, 19(5), 425-9.
  54. Boockvar KS, Livote EE, Goldstein N, Nebeker JR, Siu A, Fried T (2010). Electronic health records and adverse drug events after patient transfer. Qual Saf Health Care, 19(5), e16.
  55. Bennett CL, Nebeker JR (2010). Reply to M.L. Lanthier et al [Letter to the editor]. J Clin Oncol.
  56. Moore C, Li J, Hung CC, Downs J, Nebeker JR (2009). Predictive value of alert triggers for identification of developing adverse drug events. J Patient Saf, 5(4), 223-8.
  57. Richey EA, Lyons EA, Nebeker JR, Shankaran V, McKoy JM, Luu TH, Nonzee N, Trifilio S, Sartor O, Benson AB 3rd, Carson KR, Edwards BJ, Gilchrist-Scott D, Kuzel TM, Raisch DW, Tallman MS, West DP, Hirschfeld S, Grillo-Lopez AJ, Bennett CL (2009). Accelerated approval of cancer drugs: improved access to therapeutic breakthroughs or early release of unsafe and ineffective drugs? J Clin Oncol, 27(26), 4398-405.
  58. Boockvar KS, Liu S, Goldstein N, Nebeker J, Siu A, Fried T (2009). Prescribing discrepancies likely to cause adverse drug events after patient transfer. Qual Saf Health Care, 18(1), 32-6.
  59. Olola CH, Rowan B, Narus S, Smith M, Hastings T, Poynton M, Nebeker J, Hales J, Evans RS (2009). Implementation of an emergency medical card and a continuity of care report using continuity of care standard. Methods Inf Med, 48(6), 519-30.
  60. Mull HJ, Nebeker JR (2008). Informatics tools for the development of action-oriented triggers for outpatient adverse drug events. AMIA Annu Symp Proc, 505-9.
  61. Kaafarani, Haytham, Savitz, Lucy, Shin, Marlena, Rosen, Amy, Shimada, Stephanie, Rivard, Peter, Long, Brenna, Mull, Hillary, Nebeker, Jonathan (2008). Feasibility and Development of Trigger Tools for Surveillance of Adverse Events in Ambulatory Surgery [Abstract]. New England Surgical Society 89th meeting.
  62. Hougland P, Nebeker J, Pickard S, Van Tuinen M, Masheter C, Elder S, Williams S, Xu W, Henriksen K, Battles JB, Keyes MA, Grady ML (2008). Using ICD-9-CM Codes in Hospital Claims Data to Detect Adverse Events in Patient Safety Surveillance. [Review].
  63. Sauer BC, Shinogle JA, Xu W, Samore M, Nebeker J, Liu Z, Rupper R, Lux L, Amoozegar J, Lohr KN (August 2008). Improving Patient Safety and Pharmacovigilance: Methods Using Observational Data and Cohort Studies. Agency for Healthcare Research and Quality.
  64. Weir CR, Nebeker JR (2007). Critical issues in an electronic documentation system. AMIA Annu Symp Proc, 786-90.
  65. Nebeker JR, Yarnold PR, Soltysik RC, Sauer BC, Sims SA, Samore MH, Rupper RW, Swanson KM, Savitz LA, Shinogle J, Xu W (2007). Developing indicators of inpatient adverse drug events through nonlinear analysis using administrative data. Med Care, 45(10 Supl 2), S81-8.
  66. Rupper RW, Bair BD, Sauer BC, Nebeker JR, Shinogle J, Samore M (2007). Out-of-pocket pharmacy expenditures for veterans under medicare part D. Med Care, 45(10 Supl 2), S77-80.
  67. Samore MH, Shen S, Greene T, Stoddard G, Sauer B, Shinogle J, Nebeker J, Harbarth S (2007). A simulation-based evaluation of methods to estimate the impact of an adverse event on hospital length of stay. Med Care, 45(10 Supl 2), S108-15.
  68. Bennett CL, Nebeker JR, Yarnold PR, Tigue CC, Dorr DA, McKoy JM, Edwards BJ, Hurdle JF, West DP, Lau DT, Angelotta C, Weitzman SA, Belknap SM, Djulbegovic B, Tallman MS, Kuzel TM, Benson AB, Evens A, Trifilio SM, Courtney DM, Raisch DW (2007). Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers. Arch Intern Med, 167(10), 1041-9.
  69. Phansalkar S, Hoffman JM, Nebeker JR, Hurdle JF (2007). Pharmacists versus nonpharmacists in adverse drug event detection: a meta-analysis and systematic review. Am J Health Syst Pharm, 64(8), 842-9.
  70. Weir CR, Nebeker JJ, Hicken BL, Campo R, Drews F, Lebar B (2007). A cognitive task analysis of information management strategies in a computerized provider order entry environment. J Am Med Inform Assoc, 14(1), 65-75.
  71. Weir CR, Nebeker JR (2007). Critical Issues in an Electronic Documentation System. Homer Warner Award for Best Paper at Fall AMIA 2007. AMIA Proceedings, Washington, DC.
  72. Weir CR, Nebeker JR (2007). Critical Issues in an Electronic Documentation System. Homer Warner Award for Best Paper at Fall AMIA 2007. AMIA Proceedings, Washington, DC.
  73. Weir CR, Hicken BL, Rappaport HS, Nebeker JR (2006). Crossing the quality chasm: the role of information technology departments. Am J Med Qual, 21(6), 382-93.
  74. Sauer B, Shinogle JA, Xu W, Samore M, Nebeker J, Rupper R, Lux L, Amoozegar J, Lohr K (2006). Medicare Prescription Drug Data Development: Methods for Improving Patient Safety and Pharmacovigilance Using Observational Data, RTI International DEcIDE Center. Agency for Healthcare Research and Quality.
  75. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, Davidson CJ, McKoy JM, Raisch DW, Whisenant BK, Yarnold PR, Belknap SM, West DP, Gage JE, Morse RE, Gligoric G, Davidson L, Feldman MD (2006). Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol, 47(1), 175-81.
  76. Xu W, Pickard S, Silver MP, Hougland P, Mashter C, Donnely S, Nebeker J, Samore M, Williams SD (2006). Patient Safety Events in Utah, 2001.
  77. Nebeker JR, Bennett CL (2005). Reducing adverse drug events in the outpatient chemotherapy setting: attention must be paid. Cancer, 104(11), 2289-91.
  78. Evans RS, Lloyd JF, Stoddard GJ, Nebeker JR, Samore MH (2005). Risk factors for adverse drug events: a 10-year analysis. Ann Pharmacother, 39(7-8), 1161-8.
  79. Nebeker JR, Hoffman JM, Weir CR, Bennett CL, Hurdle JF (2005). High rates of adverse drug events in a highly computerized hospital. Arch Intern Med, 165(10), 1111-6.
  80. Bennett CL, Nebeker JR, Lyons EA, Samore MH, Feldman MD, McKoy JM, Carson KR, Belknap SM, Trifilio SM, Schumock GT, Yarnold PR, Davidson CJ, Evens AM, Kuzel TM, Parada JP, Cournoyer D, West DP, Sartor O, Tallman MS, Raisch DW (2005). The Research on Adverse Drug Events and Reports (RADAR) project. JAMA, 293(17), 2131-40.
  81. Weir C, Hoffman J, Nebeker JR, Hurdle JF (2005). Nurse's role in tracking adverse drug events: the impact of provider order entry. Nurs Adm Q, 29(1), 39-44.
  82. Weir C, Nebeker J, Hicken B (2005). Evaluation of Care Management Software. VA National Office of Chief Information Office Internal Report..
  83. Weir C, Nebeker J, Hicken B (2005). Evaluation of Care Management Software. VA National Office of Chief Information Office Internal Report..
  84. Nebeker JR, Barach P, Samore MH (2004). Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med, 140(10), 795-801.
  85. Nebeker JR (2004). ConSenis: Mission critical, resident-management, and heath record database for assisted living [Web]. Sensis Management, Inc.
  86. Ladewski LA, Belknap SM, Nebeker JR, Sartor O, Lyons EA, Kuzel TC, Tallman MS, Raisch DW, Auerbach AR, Schumock GT, Kwaan HC, Bennett CL (2003). Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project. J Clin Oncol, 21(20), 3859-66.
  87. Nebeker JR, Hurdle JF, Bair BD (2003). Future history: medical informatics in geriatrics. J Gerontol A Biol Sci Med Sci, 58(9), M820-5.
  88. Hurdle JF, Weir CR, Roth B, Hoffman J, Nebeker JR (2003). Critical gaps in the world's largest electronic medical record: Ad Hoc nursing narratives and invisible adverse drug events. AMIA Annu Symp Proc, 309-12.
  89. Weir CR, Hurdle JF, Felgar MA, Hoffman JM, Roth B, Nebeker JR (2003). Direct text entry in electronic progress notes. An evaluation of input errors. Methods Inf Med, 42(1), 61-7.
  90. Nebeker JR, Hurdle JF, Hoffman JM, Roth B, Weir CR, Samroe MH (2002). Developing a taxonomy for research in adverse drug events: potholes and signposts. J Am Med Inform Assoc, 9(6 Suppl), S80-5.
  91. Nebeker JR, Hurdle JF, Hoffman J, Roth B, Weir CR, Samore M (2001). Developing a taxonomy for research in adverse drug events: potholes and signposts. Proceedings of the American Medical Informatics Association Annual Fall Symposium, 493-7.
  92. Nebeker JR, Hurdle JF, Hoffman J, Roth B, Weir CR, Samore MH (2001). Developing a taxonomy for research in adverse drug events: potholes and signposts. Proc AMIA Symp, 493-7.
  93. Nebeker JR (1994). MechInfect, An interactive database of microbiology and basic infectious disease designed for medical students [Web].
  94. Nebeker JR (1994). An interactive model of membrane electrochemistry designed for medical students [Web]. North East Medical Software, Consortium.
  95. Harris CP, Alderson K, Nebeker J, Holds JB, Anderson RL (1991). Histologic features of human orbicularis oculi treated with botulinum A toxin. Arch Ophthalmol, 109(3), 393-5.
  96. Harris CP, Alderson K, Nebeker J, Holds JB, Anderson RL (1991). Histologic features of human orbicularis oculi treated with botulinum A toxin. Arch Ophthalmol, 109(10), 393-5.

Global Impact